Back to FDA Applications sponsored by GLAXOSMITHKLINE

FDA Drug Application 022345 by GLAXOSMITHKLINE

Application Number022345
Application Type New Drug Application
Most Recent Label Available Flag
Current Patent Flag
Action Type Approval
Chemical Type New molecular entity (NME)
Therapeutic Potential Standard
Orphan Code 

Action TypeDuplicate CounterAction DateDocument TypeApplication Document IDSequence NumberDocument TitleDocument URLDocument Date
AP06/10/2011N29151000 6/15/2011
AP06/10/2011N29182000 6/16/2011
AP06/10/2011N29205000 6/17/2011
AP06/10/2011N29467000 7/11/2011
AP06/10/2011N29468000 7/11/2011
AP06/10/2011N37665000 11/1/2013
AP03/19/2012SLR32163001 3/19/2012
AP03/19/2012SLR32169001 3/23/2012
AP09/6/2013SLR36997006 9/9/2013
AP09/6/2013SLR37042006 9/11/2013
AP06/6/2013SLR36244007 6/7/2013
AP06/6/2013SLR36269007 6/11/2013
AP011/25/2015SLR44618009 11/27/2015
AP05/26/2015SLR42925010 5/28/2015
AP05/26/2015SLR42943010 5/29/2015
AP05/20/2016SLR46112011 5/23/2016
AP05/20/2016SLR46116011 5/24/2016

Back to FDA Applications sponsored by GLAXOSMITHKLINE

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer

Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.